Dapagliflozin Tablet

$500.00

Dapagliflozin Tablets 5 mg is an oral antidiabetic medication belonging to the SGLT2 (sodium-glucose cotransporter-2) inhibitor class. It works by reducing the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine and lower blood sugar levels. Dapagliflozin is used to manage type 2 diabetes mellitus and is effective in improving glycemic control, reducing the risk of cardiovascular events, and promoting weight loss. It can be used alone or in combination with other antidiabetic agents, including insulin, for comprehensive diabetes management.


Recommended Usage:

  • Indications:
    • Management of type 2 diabetes mellitus in adults, particularly in patients who do not achieve adequate glycemic control with diet, exercise, and other medications.
    • Reducing the risk of hospitalization for heart failure in patients with type 2 diabetes.
    • May also be used as an adjunct therapy in patients with chronic kidney disease (CKD) or heart failure, as recommended by healthcare providers.
  • Dosage and Administration:
    • The usual dose is 5 mg once daily, taken with or without food.
    • Dosage may be increased to 10 mg daily if additional glycemic control is required, as determined by the healthcare provider.
    • Regular kidney function assessment is recommended before and during treatment.
    • Patients should maintain adequate hydration to reduce the risk of dehydration or urinary tract infections.
  • Precautions:
    • Not recommended for patients with severe renal impairment, type 1 diabetes, or a history of diabetic ketoacidosis.
    • Use with caution in patients with a history of recurrent urinary tract or genital infections.
    • Monitor for signs of dehydration, particularly in elderly patients or those on diuretics.
    • Pregnant or breastfeeding women should only use this medication under medical advice.
    • Discontinue use in case of severe infections, surgery, or medical emergencies that require strict glycemic control.
Category: Tag:
Share :

Description

Key Benefits:

  • Improved Glycemic Control: Effectively lowers blood glucose levels by increasing glucose excretion through the urine.
  • Cardiovascular and Renal Protection: Reduces the risk of hospitalization for heart failure and may benefit patients with CKD.
  • Weight Management: Promotes modest weight loss as an additional benefit of therapy.
  • Convenient Dosing: Once-daily dosing ensures ease of use and better patient adherence.
  • Well-Tolerated: Generally associated with a low risk of hypoglycemia when used as monotherapy.

Reviews

There are no reviews yet.

Be the first to review “Dapagliflozin Tablet”

Your email address will not be published. Required fields are marked *